AVPT vs. ZVRA
AVPT (AvePoint, Inc.) and ZVRA (Zevra Therapeutics Inc.) are both stocks. AVPT operates in Software - Infrastructure (Technology), while ZVRA operates in Biotechnology (Healthcare). Over the past 3 years, AVPT returned 18.94%/yr vs 29.24%/yr for ZVRA. At a 0.25 correlation, their price movements are largely independent.
Performance
AVPT vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVPT achieves a -18.72% return, which is significantly lower than ZVRA's 21.43% return.
AVPT
- 1D
- -2.00%
- 1M
- 10.58%
- YTD
- -18.72%
- 6M
- -11.66%
- 1Y
- -39.98%
- 3Y*
- 18.94%
- 5Y*
- —
- 10Y*
- —
ZVRA
- 1D
- -5.31%
- 1M
- 8.04%
- YTD
- 21.43%
- 6M
- 33.17%
- 1Y
- 25.64%
- 3Y*
- 29.24%
- 5Y*
- -0.40%
- 10Y*
- -20.83%
AVPT vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
AVPT AvePoint, Inc. | -18.72% | -15.87% | 101.10% | 99.76% | -34.66% | -47.36% |
ZVRA Zevra Therapeutics Inc. | 21.43% | 7.43% | 27.33% | 42.70% | -47.30% | -32.74% |
Correlation
The correlation between AVPT and ZVRA is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 6, 2021 | 0.25 |
Fundamentals
AVPT:
$2.55B
ZVRA:
$655.31M
AVPT:
$0.20
ZVRA:
$2.16
AVPT:
55.68
ZVRA:
5.03
AVPT:
5.85
ZVRA:
5.11
AVPT:
5.82
ZVRA:
3.18
AVPT:
$443.68M
ZVRA:
$122.29M
AVPT:
$326.90M
ZVRA:
$104.94M
AVPT:
$53.29M
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVPT vs. ZVRA — Risk / Return Rank
AVPT
ZVRA
AVPT vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AvePoint, Inc. (AVPT) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AVPT | ZVRA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.89 | 0.43 | -1.32 |
Sortino ratioReturn per unit of downside risk | -1.11 | 1.05 | -2.16 |
Omega ratioGain probability vs. loss probability | 0.85 | 1.13 | -0.28 |
Calmar ratioReturn relative to maximum drawdown | -0.73 | 0.63 | -1.36 |
Martin ratioReturn relative to average drawdown | -1.17 | 1.10 | -2.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AVPT | ZVRA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.89 | 0.43 | -1.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.01 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.26 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.02 | -0.27 | +0.25 |
Drawdowns
AVPT vs. ZVRA - Drawdown Comparison
The maximum AVPT drawdown since its inception was -69.96%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for AVPT and ZVRA.
Loading charts...
Drawdown Indicators
| AVPT | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.96% | -99.27% | +29.31% |
Max Drawdown (1Y)Largest decline over 1 year | -54.04% | -43.47% | -10.57% |
Max Drawdown (3Y)Largest decline over 3 years | -55.03% | -43.47% | -11.56% |
Max Drawdown (5Y)Largest decline over 5 years | — | -74.01% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.85% | — |
Current DrawdownCurrent decline from peak | -43.52% | -97.12% | +53.60% |
Average DrawdownAverage peak-to-trough decline | -36.04% | -86.38% | +50.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.73% | 24.81% | +8.92% |
Volatility
AVPT vs. ZVRA - Volatility Comparison
AvePoint, Inc. (AVPT) has a higher volatility of 18.42% compared to Zevra Therapeutics Inc. (ZVRA) at 17.46%. This indicates that AVPT's price experiences larger fluctuations and is considered to be riskier than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVPT | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.42% | 17.46% | +0.96% |
Volatility (6M)Calculated over the trailing 6-month period | 31.67% | 36.15% | -4.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.22% | 59.83% | -14.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.89% | 60.17% | -13.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.89% | 81.33% | -34.44% |
Dividends
AVPT vs. ZVRA - Dividend Comparison
Neither AVPT nor ZVRA has paid dividends to shareholders.
Financials
AVPT vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between AvePoint, Inc. and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AVPT and ZVRA have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVPT has higher volatility (18.42%) compared to ZVRA (17.46%). In terms of maximum drawdown, AVPT dropped -69.96% vs ZVRA's -99.27%.
ZVRA currently has the higher Sharpe Ratio (0.43 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVPT and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer